99068-59-4 Usage
Uses
Used in Pharmaceutical and Medicinal Applications:
N-(7-AMINO-2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YL)-ACETAMIDE is used as a potential active pharmaceutical ingredient for the development of new drugs. Its unique structure and potential biological activity make it a promising candidate for various therapeutic applications.
Used in Chemical Synthesis:
N-(7-AMINO-2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YL)-ACETAMIDE is used as a key intermediate in the synthesis of other compounds with potential therapeutic properties. Its versatile chemical structure allows for further functionalization and modification to create new molecules with specific biological activities.
Further research and testing are required to fully understand the properties and potential uses of N-(7-AMINO-2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YL)-ACETAMIDE, as well as to explore its applications in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 99068-59-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,9,0,6 and 8 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 99068-59:
(7*9)+(6*9)+(5*0)+(4*6)+(3*8)+(2*5)+(1*9)=184
184 % 10 = 4
So 99068-59-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N2O3/c1-6(13)12-8-5-10-9(4-7(8)11)14-2-3-15-10/h4-5H,2-3,11H2,1H3,(H,12,13)
99068-59-4Relevant academic research and scientific papers
Synthesis of 6,7-ethylenedioxyquinoxalines and pyrido[2,3-b]pyrazines as intermediates in the preparation of antineoplastic agents
Mateu,Capilla,Harrak,Pujol
, p. 5241 - 5250 (2007/10/03)
A convenient procedure for the synthesis of quinoxalines and pyridopyrazines has been developed from aryldiamines. The condensation of aminocarbamates such as 12 with ethyl 2,3-dibromopropionate provide the quinoxaline 14 directly, in a one-step operation. The methodology reported herein represents an alternative to condensation of o-phenylenediamines with α-dicarbonyl compounds for the quinoxalines formation. The same procedure was applied to the 2,3-diaminopyridine to obtain the corresponding pyridopyrazines.
